Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Claritas Capital is an alternative investments firm founded in 2002 and headquartered in Nashville, Tennessee. The firm has deployed over $1 billion in capital across various sectors, including private equity, venture capital, real estate, and debt investments. Claritas Capital emphasizes partnerships with founders, entrepreneurs, and strategic partners to drive growth and innovation in its portfolio companies.
As of now, Claritas Capital manages a diverse portfolio of 76 companies, with a significant focus on healthcare and technology. The firm operates with a multi-strategy approach, allowing it to invest in both venture capital and real estate. Claritas Capital has established itself as a key player in the Nashville investment community, being a member of the Nashville Health Care Council and the Nashville Innovation Alliance.
Over the years, Claritas Capital has achieved notable milestones, including the launch of specialized programs like Claritas Health Ventures, which focuses on healthcare investments, and Claritas Athena Ventures, aimed at supporting female-led companies. The firm’s commitment to purpose-driven investing aligns with its goal of enhancing clinical excellence and improving patient and consumer experiences.
Claritas Capital primarily invests in two sectors: venture capital and real estate. In venture capital, the firm targets established business models in healthcare, technology, media, and entertainment, providing investments ranging from $2 million to $5 million. The firm focuses on companies at the Seed, Seed+, Series A, Series B, and Series C stages, ensuring that it partners with businesses that have demonstrated potential for growth.
In addition to its venture capital focus, Claritas Capital partners with developers to fund various commercial projects in growing Southeastern markets. The firm’s investment strategy emphasizes purpose-driven companies that operate at the intersection of clinical excellence and patient/consumer experience. This approach allows Claritas Capital to back founders who are committed to making a positive impact in their respective industries.
Claritas Capital's geographic focus is primarily on North America, specifically the United States. The firm seeks to invest in sectors such as healthcare, fintech, media, and consumer products, ensuring a diverse portfolio that aligns with its investment thesis.
Claritas Capital's portfolio includes a diverse range of companies across various sectors, particularly in healthcare and technology. Notable active healthcare companies include:
In addition to healthcare, Claritas Capital has invested in technology and services companies such as:
John Chadwick: Founder and Managing Partner. John has extensive experience in venture capital and private equity, having led numerous successful investments in healthcare and technology.
Theresa Sexton: Managing Partner. Theresa brings a wealth of knowledge in operational management and strategic planning, contributing to the firm's investment decisions.
Bob Fisher: Managing Partner. Bob has a strong background in finance and investment management, focusing on portfolio growth and performance.
Jordan Michael: CFO and Chief Compliance Officer. Jordan oversees the firm's financial operations and compliance, ensuring adherence to regulatory standards.
Tania Grant: Partner. Tania specializes in healthcare investments, leveraging her expertise to identify promising opportunities in the sector.
Patrick Warfield: Partner. Patrick focuses on technology investments, bringing a deep understanding of market trends and innovation.
Caroline Hipps: Executive Director. Caroline manages day-to-day operations and supports portfolio companies in their growth strategies.
Leah Glover Hayes: Director. Leah is involved in sourcing new investment opportunities and conducting due diligence.
Donna Altshuler: Director. Donna focuses on strategic partnerships and business development within the portfolio.
John Gordon: Principal. John plays a key role in investment analysis and portfolio management.
Francis Stanley: Principal. Francis specializes in market research and competitive analysis for potential investments.
Kathy Harris: Venture Partner. Kathy brings expertise in venture capital and startup growth, supporting portfolio companies.
Walter de Brouwer: Partner, SM&E. Walter focuses on social media and entertainment investments, leveraging his industry knowledge.
Dr. Lisa Piercey: Strategic Advisor. Dr. Piercey provides insights into healthcare investments, enhancing the firm's strategic direction.
Sam de Brouwer: Strategic Advisor. Sam offers expertise in technology and innovation, guiding investment strategies.
Laura Hutfless: Strategic Advisor. Laura supports the firm with her extensive experience in business development and growth strategies.
To pitch Claritas Capital, founders should use the contact form available on their website at claritascapital.com. It is essential to include a comprehensive pitch deck that outlines the business model, market opportunity, and financial projections. Claritas Capital prefers detailed information that demonstrates the startup's potential for growth and alignment with their investment thesis.
Response times can vary, but founders should expect to hear back within a few weeks. Warm introductions are encouraged, as they can facilitate a more favorable review process. Claritas Capital values connections that can enhance the credibility of the pitch.
Claritas Capital operates several specialized programs to enhance its investment strategy:
In 2023, Claritas Capital announced the launch of Claritas Athena Ventures, a program aimed at empowering female founders in the startup ecosystem. This initiative reflects the firm's commitment to diversity and inclusion in its investment strategy.
In early 2023, Claritas Capital made headlines for its investment in Alchemy 43, a provider of aesthetic services, highlighting its focus on healthcare and consumer services.
Additionally, the firm has been active in deploying capital across various sectors, with a notable emphasis on healthcare technology, further solidifying its reputation as a key player in the venture capital space.
What are Claritas Capital's investment criteria?
Claritas Capital primarily invests in established business models within healthcare, technology, media, and fintech sectors. The firm focuses on companies at the Seed to Series C stages, providing check sizes ranging from $2 million to $5 million.
How can I pitch to Claritas Capital?
Founders can pitch to Claritas Capital through their website at claritascapital.com. It is recommended to include a detailed business plan, market analysis, and financial projections in the pitch deck.
What makes Claritas Capital different from other investors?
Claritas Capital emphasizes purpose-driven investing, focusing on companies that enhance clinical excellence and improve patient and consumer experiences. The firm also has a commitment to supporting female founders through initiatives like Claritas Athena Ventures.
What is the geographic scope of Claritas Capital's investments?
Claritas Capital primarily invests in North America, specifically within the United States. The firm seeks opportunities in growing Southeastern markets for its real estate investments.
What is Claritas Capital's post-investment involvement like?
Claritas Capital actively supports its portfolio companies by leveraging its extensive network and expertise in healthcare and technology. The firm focuses on partnerships that enhance growth and innovation within its investments.
What is the size of Claritas Capital's funds?
Claritas Capital has a total fund size of $1 billion, with a specific focus on deploying capital across various sectors, including healthcare and technology.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.